Brain tumours remain the most common cause of death from childhood cancer. Paediatric high-grade gliomas (pHGG) in particular ...

Results from the company’s Phase I/II trial showed the injectable therapy to have an effective half-life of 91.4 hours.

NiKang Therapeutics has concluded the first cohort dosing in the open-label Phase I trial of NKT3964 as a monotherapy for ...

Canadian researchers have developed an effective new technique for identifying aggressive medulloblastoma—the most common type of malignant brain tumour in children—and potentially sparing young ...

Regina Gumenyuk, Adjunct Professor at Tampere University, is exploring a novel imaging platform for early and precise cancer ...

Uncover the mysteries of Neuroendocrine Tumours (NETs), a rare and often misdiagnosed condition. Expert insights reveal why ...

The myTomorrows expert cautioned that if your headache is accompanied by other symptoms, it could suggest that it's not just ...

This worrying symptom should send people to the GP as soon as possible. It could be pointing to an array of health issues but ...

Type 1 dendritic cells are key to initiate and maintain anti-tumoral T-cell responses in diverse tumour tissues. Our lab focuses on tissue-specific properties of cDC1 in lung tumours, focusing on the ...

Teddi Mellencamp has revealed she has multiple tumours on her brain and lungs following her recent surgery. The Real ...